Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm

Blastic plasmacytoid dendritic cell neoplasm is an aggressive hematologic malignancy with a poor prognosis. No consensus regarding optimal treatment modalities is currently available. Targeting the nuclear factor-kappa B pathway is considered a promising approach since blastic plasmacytoid dendritic...

詳細記述

書誌詳細

主要な著者:	Laure Philippe, Adam Ceroi, Elodie Bôle-Richard, Alizée Jenvrin, Sabeha Biichle, Sophie Perrin, Samuel Limat, Francis Bonnefoy, Eric Deconinck, Philippe Saas, Francine Garnache-Ottou, Fanny Angelot-Delettre
フォーマット:	Artigo
言語:	Inglês
出版事項:	Ferrata Storti Foundation 2017-11-01
シリーズ:	Haematologica
オンライン･アクセス:	https://haematologica.org/article/view/8249
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!